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RERANDOMIZATION TO IMPROVE COVARIATE BALANCE IN
EXPERIMENTS1
By Kari Lock Morgan and Donald B. Rubin
Duke University and Harvard University
Randomized experiments are the “gold standard” for estimating
causal effects, yet often in practice, chance imbalances exist in co-
variate distributions between treatment groups. If covariate data are
available before units are exposed to treatments, these chance im-
balances can be mitigated by first checking covariate balance before
the physical experiment takes place. Provided a precise definition of
imbalance has been specified in advance, unbalanced randomizations
can be discarded, followed by a rerandomization, and this process
can continue until a randomization yielding balance according to the
definition is achieved. By improving covariate balance, rerandomiza-
tion provides more precise and trustworthy estimates of treatment
effects.
1. A brief history of rerandomization. Randomized experiments are the
“gold standard” for estimating causal effects, because randomization bal-
ances all potential confounding factors on average. However, if in a particular
experiment, a randomization creates groups that are notably unbalanced on
important covariates, should we proceed with the experiment, rather than
rerandomizing and conducting the experiment on balanced groups?
With k independent covariates, the chance of at least one covariate show-
ing a “significant difference” between treatment and control groups, at sig-
nificance level α, is 1 − (1 − α)k. For a modest 10 covariates and a 5%
significance level, this probability is 40%. “Most experimenters on carry-
ing out a random assignment of plots will be shocked to find how far from
equally the plots distribute themselves” [Fisher (1926)]. The danger of re-
lying on pure randomization to balance covariates has been described in
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Also, there exists much discussion historically over whether randomization
should be preferred over a purposefully balanced assignment [Gosset (1938);
Yates (1939); Greenberg (1951); Harville (1975); Arnold (1986); Kempthorne
(1986)]. Our view is that with rerandomization, we can retain the advantages
of randomization, while also ensuring balance.
It is standard in randomized experiments today to collect covariate data
and check for covariate balance, yet typically this is done after the experi-
ment has started. If covariate data are available before the physical exper-
iment has started, a randomization should be checked for balance before
the physical experiment is conducted. If lack of balance is noted, as Gos-
set stated, “it would be pedantic to continue with an arrangement of plots
known beforehand to be likely to lead to a misleading conclusion” [Gosset
(1938)]. It appears that Fisher would agree. In Rubin (2008a), Rubin re-
counts the following conversation with his advisor Bill Cochran:
Rubin: What if, in a randomized experiment, the chosen randomized allo-
cation exhibited substantial imbalance on a prognostically important base-
line covariate?
Cochran: Why didn’t you block on that variable?
Rubin: Well, there were many baseline covariates, and the correct blocking
wasn’t obvious; and I was lazy at that time.
Cochran: This is a question that I once asked Fisher, and his reply was
unequivocal:
Fisher (recreated via Cochran): Of course, if the experiment had not been
started, I would rerandomize.
A similar conversation between Fisher and Savage, wherein Fisher advo-
cates rerandomization when faced with an undesirable randomization, is
documented in Savage [(1962), page 88].
Checking covariates and rerandomizing when needed for balance has been
advocated repeatedly. Sprott and Farewell (1993) recommend rerandomiza-
tion when “obvious” lack of balance is observed. Rubin (2008a) suggests
that if “important imbalances exist, rerandomize, and continue to do so
until satisfied.” For clinical trials, Worrall (2010) states that “if such base-
line imbalances are found then the recommendation . . . is to re-randomize
in the hope that this time no baseline imbalances will occur.” Cox (2009)
and Bruhn and McKenzie (2009) have advocated rerandomization, suggest-
ing either to do multiple randomizations and pick the “best,” or to specify
a bound for the difference in treatment and control covariate means for
each covariate, following the “Big Stick” method of Soares and Wu (1985),
and rerandomize until all differences are within these bounds. The latter
rerandomization method was used in Maclure et al. (2006).
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There are also many sources giving reasons not to rerandomize. Good
accounts of the debate over rerandomization can be found in Urbach (1985)
and Raynor (1986). The most common critique of rerandomization is that
forms of analysis utilizing Gaussian distribution theory are no longer valid
[Fisher (1926); Anscombe (1948a); Grundy and Healy (1950); Holschuh
(1980); Bailey (1983); Urbach (1985); Bailey (1986); Bailey and Rowley
(1987)]. Rerandomization changes the distribution of the test statistic, most
notably by decreasing the true standard error, thus traditional methods of
analysis that do not take this into account will result in overly “conservative”
inferences in the sense that tests will reject true null hypotheses less often
than the nominal level and confidence intervals will cover the true value more
often than the nominal level. However, randomization-based inference is still
valid [Anscombe (1948a); Kempthorne (1955); Brillinger, Jones and Tukey
(1978); Tukey (1993); Rosenberger and Lachin (2002); Moulton (2004)], be-
cause the rerandomization can be accounted for during analysis.
All other critiques of rerandomization, of which we are aware, deal with
“ad-hoc” rerandomization, that is, rejecting randomizations without spec-
ifying a rejection criterion in advance. We only advocate rerandomization
if the decision to rerandomize or not is based on a pre-specified criterion.
By specifying an objective rerandomization rule before randomizing, and
then analyzing results using randomization-based methods, we can, in most
circumstances, finesse all existing criticisms of rerandomizing.
Some may think that rerandomization is unnecessary with large sample
sizes, because as the sample size increases, the difference in covariate means
between groups gets smaller, essentially proportional to the square root of
the sample size. However, at the same rate, confidence intervals and signifi-
cance tests are getting more sensitive to small differences in outcome means,
which can be driven by small differences in covariate means.
Despite the ongoing discussion about rerandomization and the fact that
it is widely used in practice [Holschuh (1980); Urbach (1985); Bailey and
Rowley (1987); Imai, King and Stuart (2008); Bruhn and McKenzie (2009)],
little has been published on the mathematical implications of rerandomiza-
tion. Remarkably, it appears that no source even makes explicit the condi-
tions under which rerandomization is valid. Although a few rerandomization
methods have been proposed [Moulton (2004); Maclure et al. (2006); Bruhn
and McKenzie (2009); Cox (2009)], the implications have not been theoreti-
cally explored, to the best of our knowledge. The only published theoretical
results accompanying a rerandomization procedure appear to be those in
Cox (1982), which proposed rerandomization to lower the sampling vari-
ance of covariance-adjusted estimates. Here we aim to fill these lacuna by
(a) making explicit the sufficient conditions under which rerandomization
is valid, (b) describing in detail a principled procedure for implementing
rerandomization and (c) providing corresponding theoretical results.
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Fig. 1. Procedure for implementing rerandomization.
2. Rerandomization in general.
2.1. Procedure. The procedure for implementing rerandomization is de-
picted in Figure 1, and has the following steps:
(1) Collect covariate data.
(2) Specify a balance criterion determining when a randomization is ac-
ceptable.
(3) Randomize the units to treatment groups.
(4) Check the balance criterion; if the criterion is met, go to Step (5).
Otherwise, return to Step (3).
(5) Conduct the experiment using the final randomization obtained in
Step (4).
(6) Analyze the results using a randomization test, keeping only simu-
lated randomizations that satisfy the balance criterion specified in Step (2).
Let x be the n× k covariate matrix representing k covariates measured
on n experimental units. Here we assume that a sample of units has already
been selected and is fixed. Because we are not considering the sampling
mechanism, we are only interested in the extent to which a causal effect
estimate obtained in this randomized experiment is a good estimate of the
true causal effect within the selected sample. The x matrix includes all the
observed covariates for which balance between groups is desired, which may
include original covariates, and any functions of original covariates, such
as transformations, powers and interactions. Let W be the n-dimensional
treatment assignment vector indicating the treatment group for each unit.
The rerandomization criterion is based on a row-exchangeable scalar func-
tion of x and W.
ϕ(x,W) =
{
1, if W is an acceptable randomization,
0, if W is not an acceptable randomization.
The function ϕ can vary depending on the relative importance of balancing
different covariates, on the level of covariate balance desired and on the
computational power available, but it is specified in advance.
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More generally, we can define a set of acceptance criteria, S = {ϕs}, from
which we choose at each step, s, either deterministically or stochastically,
where this choice can depend on the step, so that, for example, we can
become more lenient as the steps increase without success. In this more
general situation, ϕs(x,W) denotes the acceptance criterion for step s. Al-
though our theoretical results in Sections 2 and 3 hold for this more general
setup, in practice we expect that the common choice will be one function
for all steps, and to avoid notational clutter, we present results with one
criterion.
Once ϕ has been specified, units are randomized to treatment groups
(Step 3). In the simplest form of rerandomization, this can be done with no
restrictions; for example, randomly choose an assignment vectorW from all
possible vectors, or equivalently from all possible partitions of the units into
groups. In practice, the initial randomization is typically done with some
restriction to equalize treatment group sizes.
Rerandomization is simply a tool that allows us to draw from some prede-
termined set of acceptable randomizations, {W | ϕ(x,W) = 1}. Rerandom-
ization is analogous to rejection sampling; a way to draw from a set that
may be tedious to enumerate. Specifying a set of acceptable randomizations
and then choosing randomly from this set is recommended by Kempthorne
(1955, 1986) and Tukey (1993), and Moulton (2004) notes that rerandom-
ization may be required for implementation of this idea when the set of
acceptable randomizations is difficult to enumerate a priori.
Within this framework, rerandomization simply generalizes classical ex-
perimental designs. For the basic completely randomized experiment with
fixed sample sizes in each treatment group, ϕ(x,W) = 1 when the num-
ber of units assigned to each group matches the predetermined group sizes.
For a randomized block experiment, ϕ(x,W) = 1 when predetermined num-
bers of units within each block are assigned to each treatment group. For
a Latin square, ϕ(x,W) = 1 when the randomization satisfies the Latin
square design. These classical designs can be readily sampled from, so reran-
domization is computationally inefficient, although equivalent, but for other
functions, ϕ, rerandomization may be a more straightforward technique.
Rerandomization can also be used together with any classical design. For
example, in a medical experiment on hypertensive drugs, we may block on
sex and a coarse categorization of baseline blood pressure, and use reran-
domization to balance the remaining covariates, including fine baseline blood
pressure.
Researchers are free to chose any function ϕ, provided it is chosen in
advance. Section 2.3 describes the conditions necessary to maintain general
unbiasedness of simple point estimation, Section 3 recommends a particu-
lar class of functions and studies theoretical properties of this choice and
Section 4 discusses some reasons for choosing an affinely invariant ϕ.
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2.2. Analysis by randomization tests. Under most forms of rerandomiza-
tion, increasing balance in the covariates will typically create more precise
estimated treatment effects, making traditional Gaussian distribution-based
forms of analysis statistically too conservative. However, the final data can
be analyzed using a randomization test, maintaining valid frequentist prop-
erties. As Fisher stated, “It seems to have escaped recognition that the
physical act of randomization . . . affords the means, in respect of any par-
ticular body of data, of examining a wider hypothesis in which no normality
of distribution is implied” [Fisher (1935)]. This physical act of randomiza-
tion need not be pure randomization, but any randomization scheme that
can be replicated when conducting the randomization test.
We are interested in the effect of treatment assignment, W, on an out-
come, y. Let yi(Wi) denote the ith unit’s, {i= 1, . . . , n}, potential outcome
under treatment assignment Wi, following the Rubin causal model [Rubin
(1974)]. Although rerandomization can be applied to any number of treat-
ment conditions, to convey essential ideas most directly, we consider only
two, and refer to these conditions as treatment and control. Let
Wi =
{
1, if treated,
0, if control.
Let Yobs(W) denote the vector of observed outcome values:
Yobs,i = yi(1)Wi + yi(0)(1−Wi),(1)
where for notational simplicity the subscript obs means obs(W). Under the
sharp null hypothesis of no treatment effect on any unit, yi(1) = yi(0) for
every i, and thus the vector Yobs is the same for every treatment assign-
ment W. Consequently, leaving Yobs fixed and simulating many acceptable
randomization assignments, W, we can empirically create the distribution
of any estimator, g(x,W,yobs), if the null hypothesis were true. To account
for the rerandomization, each simulated randomization must also satisfy
ϕ(x,W) = 1. Once the desired number of randomizations has been simu-
lated, the proportion of simulated randomizations with estimated treatment
effect as extreme or more extreme than that observed in the experiment is
the p-value. Although a full permutation test (including all the acceptable
randomizations) is necessary for an exact p-value, the number of simulated
randomizations can be increased to provide a p-value with any desired level
of accuracy. This test can incorporate whatever rerandomization procedure
was used, will preserve the significance level of the test [Moulton (2004)] and
works for any estimator. Brillinger, Jones and Tukey (1978), Tukey (1993)
and Rosenberger and Lachin [(2002), Chapter 7] suggest using randomiza-
tion tests to assess significance when restricted randomization schemes are
used.
Because analysis by a randomization test requires generating many ac-
ceptable randomizations, computational time can be important to consider
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in advance. Define pa ≡ P (ϕ= 1) to be the proportion of acceptable random-
izations. The choice of pa involves a trade-off between better balance and
computational time; smaller values of pa ensure better balance, but they also
imply a longer expected waiting time to obtain an acceptable randomiza-
tion, at least without clever computational devices. The number of random-
izations required to get one acceptable randomization follows a geometric
distribution with parameter pa, so N simulated acceptable randomizations
for a randomization test will require on average N/pa randomizations to be
generated.
The chosen pa must leave enough acceptable randomizations to perform
a randomization test. In practice this is rarely an issue, because the number
of possible randomizations is huge even for modest n. To illustrate, the
number of possible randomizations for n= {30,50,100} randomizing to two
equally sized treatment groups,
( n
n/2
)
, is on the order of {108,1014,1029},
respectively. However, for small sample sizes, care should be taken to ensure
the number of acceptable randomizations does not become too small, for
example, less than 1000.
By employing the duality between confidence intervals and tests, for addi-
tive treatment effects a confidence interval can be produced from a random-
ization distribution as the set of all values for which the observed data would
not reject such a null hypothesized value [Lehmann and Romano (2005);
Manly (2007), Section 3.5, Section 1.4]. Garthwaite (1996) provides an effi-
cient algorithm for generating a confidence interval for additive effects from
a randomization test. The assumption of additivity is statistically conser-
vative, at least asymptotically, as implied by Neyman’s [Splawa-Neyman
(1990)] results on standard errors being overestimated when assuming it
relative to the actual standard errors. A randomization test can be applied
to any sharp null hypothesis, that is, a hypothesis such that the observed
data implies specific values for all missing potential outcomes.
When the covariates being balanced are correlated with the outcome
variable, then rerandomization increases precision (Section 3.2). A random-
ization test reflects this increase in precision. Standard asymptotic-based
frequentist analysis procedures that do not take the rerandomization into
account will be statistically conservative. Not only will distribution-based
standard errors not incorporate the increase in precision, but the act of
rerandomizing itself will increase the estimated standard error beyond that
of pure randomization. If the total variance in the outcome is fixed, de-
creasing the actual sampling variance between treatment group means (by
ensuring better balance), increases the variance within groups, and it is this
variance within groups that is traditionally used to estimate the standard
error [Fisher (1926)]. Thus, although rerandomization decreases the true
standard error, it actually increases the standard error as estimated by tra-
ditional methods. For both of these reasons, the regular estimated standard
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errors will overestimate the true standard error, and using the correspond-
ing distribution-based methods of analysis after rerandomization results in
overly wide confidence intervals and less powerful tests of hypotheses.
2.3. Maintaining an unbiased estimate. Although not needed to moti-
vate rerandomization, we assume one goal is to estimate the average treat-
ment effect
τ ≡ y(1)− y(0)
(2)
=
∑n
i=1 yi(1)
n
−
∑n
i=1 yi(0)
n
.
The fundamental problem in causal inference is that, because we only ob-
serve yi(Wi) for each unit, we cannot calculate (2) directly, and we must
estimate τ using only Yobs. In this section, we assume the Stable Unit Treat-
ment Value Assumption (SUTVA) [Rubin (1980)]: the potential outcomes
are fixed and do not change with different possible assignment vectors W.
The average treatment effect τ is usually estimated by the difference in
observed sample means,
τˆ ≡ Y obs,T − Y obs,C ,
where
Y obs,T ≡
∑
i=1Wiyi(1)∑n
i=1Wi
and Y obs,C ≡
∑n
i=1(1−Wi)yi(0)∑n
i=1(1−Wi)
.
Theorem 2.1. Suppose
∑n
i=1Wi =
∑n
i=1(1−Wi) and ϕ(x,W) = ϕ(x,
1−W); then E(τˆ | x, ϕ= 1) = τ .
Proof. Under the specified conditions, W and 1−W are exchange-
able. Therefore, after rerandomization E(Wi | x, ϕ= 1) = E(1−Wi | x, ϕ= 1)
∀i, so E(Wi | x, ϕ= 1) = E(1−Wi | x, ϕ= 1) = 1/2 ∀i. Hence
E(τˆ | x, ϕ= 1) = E
(∑n
i=1WiYi,obs
n/2
−
∑n
i=1(1−Wi)Yi,obs
n/2
∣∣∣ x, ϕ= 1
)
= E
(∑n
i=1Wiyi(1)
n/2
−
∑n
i=1(1−Wi)yi(0)
n/2
∣∣∣ x, ϕ= 1
)
=
∑n
i=1E(Wi | ϕ= 1)yi(1)
n/2
−
∑n
i=1(1−E(Wi | x, ϕ= 1))yi(0)
n/2
=
∑n
i=1(1/2)yi(1)
n/2
−
∑n
i=1(1/2)yi(0)
n/2
= τ. 
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Theorem 2.1 holds for all outcome variables. Corollary 2.2 follows by the
same logic.
Corollary 2.2. If
∑n
i=1Wi =
∑n
i=1(1 − Wi) and ϕ(x,W) = ϕ(x,
1−W), then E(V T − V C | x, ϕ = 1) = 0 for any observed or unobserved
covariate V .
If sample sizes are not fixed in advance, but each unit has E(Wi | x) =
1/2 in the initial randomization, τˆ is only necessarily an unbiased estimate
under the assumption of additivity. As a small example under nonadditivity,
consider x= (0,1,2), y(1) = (1,1,0) and y(0) = (0,0,1). When ϕ(x,W) = 1
if the difference in x means between the two groups is 0 and ϕ= 0 otherwise,
the only two acceptable randomizations are W= (0,1,0) and W= (1,0,1).
For either acceptable randomization, τˆ = 1/2, yet τ = 1/3. This artificial
example also illustrates that if the treatment groups are of unequal size, τˆ
will not necessarily be an unbiased estimate after rerandomization. If the
treatment group includes two units and the control group one unit, and
ϕ(x,W) is the same as before, then the only acceptable randomization is
W= (1,0,1), and once again, τˆ = 1/2, whereas τ = 1/3.
3. Rerandomization using Mahalanobis distance. To simplify the state-
ment of theoretical results, we assume the sample sizes for the treatment
and control groups are fixed in advance, with pw the fixed proportion of
treated units,
pw =
∑n
i=1Wi
n
.(3)
Let XT −XC be the k-dimensional vector of the difference in covariate
means between the treatment and control groups,
XT −XC =
x′W
npw
−
x′(1−W)
n(1− pw)
=
x′(W− pw1)
npw(1− pw)
.(4)
We consider Mahalanobis distance as a rerandomization criterion because
it is an affinely invariant scalar measure of multivariate covariate balance.
Mahalanobis distance is defined by
M ≡ (XT −XC)
′[cov(XT −XC)]
−1(XT −XC)(5)
= npw(1− pw)(XT −XC)
′ cov(x)−1(XT −XC),(6)
where cov(x) represents the sample covariance matrix of x. The quantities n,
pw and cov(x) are known and constant across randomizations. If cov(x) is
singular, for example, if k ≥ n, then cov(x)−1 can be replaced with the
pseudo-inverse of cov(x). For cluster randomized experiments, see Hansen
and Bowers (2008).
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Due to the finite population central limit theorem, XT −XC is asymptot-
ically multivariate normally distributed over its randomization distribution
[Erdo˝s and Re´nyi (1959); Ha´jek (1960)]. Normality of XT −XC is not neces-
sary for rerandomization, but assuming normality allows for the theoretical
results of this section. If XT −XC is multivariate normal, then under pure
randomization, M ∼ χ2k [Mardia, Kent and Bibby (1980), page 62]; M is
the statistic used in Hotelling’s T 2 test, but note that here M follows a χ2k
distribution because x is considered fixed.
A randomization is deemed “acceptable” wheneverM falls below a certain
threshold, a. Let pa be the proportion of randomizations that are acceptable,
so that P (M ≤ a) = pa. Either a or pa can be specified a priori, and then
the other is fixed either using M ∼ χ2k if sample sizes are large enough
or using an empirical distribution of M achieved through simulation. The
rerandomization criterion, ϕM , is
ϕM (x,W)≡
{
1, if M ≤ a,
0, if M >a.
(7)
3.1. Covariate balance under ϕM .
Theorem 3.1. Assume rerandomization is conducted using ϕM with
pw = 1/2, and the covariate means are multivariate normal; then
cov(XT −XC | x, ϕM = 1) = va cov(XT −XC | x, ),(8)
where
va ≡
2
k
×
γ(k/2 + 1, a/2)
γ(k/2, a/2)
=
P (χ2k+2 ≤ a)
P (χ2k ≤ a)
(9)
and γ denotes the incomplete gamma function: γ(b, c)≡
∫ c
0 y
b−1e−y dy.
The proof of Theorem 3.1 is in the Appendix.
In the field of matching, emphasis has been placed on “percent reduction
in bias” [Cochran and Rubin (1973)]. In the context of randomized exper-
iments there is no bias, and rerandomization instead reduces the sampling
variance of the difference in covariate means, yielding differences that are
more closely concentrated around 0. Define the percent reduction in vari-
ance, the percentage by which rerandomization reduces the randomization
variance of the difference in means, for each covariate, xj , by
100
(
var(Xj,T −Xj,C | x)− var(Xj,T −Xj,C | x, ϕ= 1)
var(Xj,T −Xj,C | x)
)
.(10)
By Theorem 3.1, the percent reduction in variance for each covariate, and
for any linear combination of these covariates, is
100(1− va)(11)
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Fig. 2. The percent reduction in variance for each covariate difference in means, as a
function of the number of covariates and the proportion of randomizations accepted.
and is shown as a function of k and pa in Figure 2, where by (9), 0 ≤
va ≤ 1. The lower the acceptance probability and the fewer covariates being
balanced, the larger the percent reduction in variance.
Notice that Theorem 3.1 holds for any covariate distribution, as long
as the sample size is large enough for the central limit theorem to ensure
normally distributed covariate means. An exact value is not needed, and an
estimate is used only to guide the choice of pa; it has no influence on the
validity of resulting inferences.
3.2. Precision of the estimated treatment effect. Rerandomization im-
proves precision, provided the outcome and covariates are correlated. Thus
researchers can increase the power of tests and decrease the width of confi-
dence intervals simply at the expense of computational time.
Theorem 3.2. If (a) rerandomization is conducted using ϕM with pw =
1/2, (b) the covariate and outcome means are normally distributed, and (c)
the treatment effect is additive, then the percent reduction in variance of τˆ is
100(1− va)R
2,(12)
where R2 represents the squared multiple correlation between y and x within
a treatment group and va is as defined in (9).
Proof. Regardless of the true relationship between the outcome and
covariates, by additivity we can write
yi(Wi) | xi = β0 + β
′xi + τWi + ei,(13)
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where β0 + β
′xi is the projection of yi onto the space spanned by (1,x),
and ei is a residual that encompasses any deviations from the linear model.
Then the estimated treatment effect, τˆ , can be expressed as
τˆ = β′(XT −XC) + τ + (eT − eC).(14)
Because τ is constant and the first and last terms are uncorrelated, we can
express the variance of τˆ as
var(τˆ) = var(β′(XT −XC)) + var(eT − eC)
(15)
= β′ cov(XT −XC)β +var(eT − eC).
By Theorem 3.1, rerandomization modifies the first term by the factor va.
Because under normality, orthogonality implies independence, the difference
in residual means is independent of the difference in covariate means, and
thus rerandomization has no affect on the second term. Therefore, the vari-
ance of τˆ after rerandomization restricting M ≤ a is
var(τˆ | x,M ≤ a) = β′ cov(XT −XC | x,M ≤ a)β +var(eT − eC | x,M ≤ a)
(16)
= vaβ
′ cov(XT −XC | x)β +var(eT − eC | x).
Let σ2e be the variance of the residuals and σ
2
y be the variance of the outcome
within each treatment group, where σ2e = σ
2
y(1−R
2). Thus
var(eT − eC | x) =
σ2e
npw(1− pw)
=
σ2y(1−R
2)
npw(1− pw)
,(17)
and
β′ cov(XT −XC | x)β = var(τˆ | x)− var(eT − eC | x)
=
σ2y − σ
2
e
npw(1− pw)
(18)
=
σ2yR
2
npw(1− pw)
.
Therefore by (16), (17) and (18), the variance of τˆ after rerandomization is
var(τˆ | x,M ≤ a) = vaβ
′ cov(XT −XC | x)β +var(eT − eC | x)
=
vaσ
2
YR
2
npw(1− pw)
+
σ2Y (1−R
2)
npw(1− pw)
= (1− (1− va)R
2)
σ2Y
npw(1− pw)
= (1− (1− va)R
2) var(τˆ | x).
Thus the percent reduction in variance is 100(1− (1− (1− va)R
2) = 100(1−
va)R
2. 
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Fig. 3. The percent reduction in variance for the estimated treatment effect, as a function
of the acceptance probability, the number of covariates, and R2.
The percent reduction in variance for the estimated treatment effect,
shown as a function of k, pa and R
2 in Figure 3, is simply the percent
reduction in variance for each covariate, scaled by R2. Because under the
specified conditions τˆ is unbiased by Theorem 2.1, 100(1− va)R
2 is not only
the percent reduction in variance in the estimated treatment effect, but also
the percent reduction in mean square error (MSE).
If regression (i.e., analysis of covariance) is used to adjust for imbalance
in a completely randomized experiment, the percent reduction in variance is
100
[(
1 +
M
n
)
R2 −
M
n
]
(19)
[Cox (1982)], where M is as in (6). Comparing (19) to (10), we see that
rerandomization can increase precision more than regression adjustment be-
cause there is no estimation of regression coefficients with the former. Note
that the highest percent reduction in variance achievable by either reran-
domization or regression is 100R2, achieved with perfect covariate mean
balance.
4. Affinely invariant rerandomization criteria. In this section we explore
the theoretical implications of choosing an affinely invariant rerandomiza-
tion criterion, meaning that for any affine transformation of x, a + bx,
ϕ(x,W) = ϕ(a+ bx,W). Measures based on inner products, such as Ma-
halanobis distance or the estimated best linear discriminant, are affinely
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invariant, as are criteria based on propensity scores estimated by linear lo-
gistic regression [Rubin and Thomas (1992)]. Results in this section parallel
those for affinely invariant matching methods [Rubin and Thomas (1992)].
In the previous sections, we regarded x as fixed, and only the random-
ization vector, W was random. In this section, to use ellipsoidal symmetry
of x, we regard both x andW as random, so expectations are over repeated
draws of x and repeated randomizations.
Theorem 4.1. If ϕ is affinely invariant, and if x is ellipsoidally sym-
metric, then
E(XT −XC | ϕ= 1) = E(XT −XC) = 0 and(20)
cov(XT −XC | ϕ= 1)∝ cov(XT −XC).(21)
Proof. First, by ellipsoidal symmetry there is an affine transformation
of x to a canonical form with mean (center) zero and covariance (inner prod-
uct) I, the k-dimensional identity matrix. The distribution of the matrix x
in the treated group of size npw and the control group of size n(1− pw) are
both independent and identically distributed samples from this zero cen-
tered spherical distribution. Any affinely invariant rule for selecting subsets
of treated and control units will be a function of affinely invariant statis-
tics in the treatment and control groups that are also zero-centered spheri-
cally symmetric. Applying ϕ creates concentric zero-centered sphere(s) that
partition the space of these statistics into regions where ϕ = 1 and ϕ = 0,
and therefore the distribution of such statistics remains zero-centered and
spherically symmetric. Transforming back to the original form completes the
proof. 
Corollary 4.2. If ϕ is affinely invariant and if x is ellipsoidally sym-
metric, then rerandomization leads to unbiased estimates of any linear func-
tion of x.
Note that, unlike Corollary 2.2, Corollary 4.2 applies no matter how the
sample sizes are chosen.
Corollary 4.3. If ϕ is affinely invariant and if x is ellipsoidally sym-
metric, then
cor(XT −XC | ϕ= 1) = cor(XT −XC).(22)
One possible method of rerandomization, suggested by Moulton (2004),
Maclure et al. (2006), Bruhn and McKenzie (2009) and Cox (2009), is to
place bounds separately on each entry of XT −XC and ensure that each
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covariate difference is within its specified caliper. However, this method is
not affinely invariant and will generally destroy the correlational structure
of XT −XC , even when x is ellipsoidally symmetric.
Analogous to “Equal Percent Bias Reducing” (EPBR) matching meth-
ods [Rubin (1976)], a rerandomization method is said to be “Equal Percent
Variance Reducing” (EPVR) if the percent reduction in variance is the same
for each covariate.
Corollary 4.4. If ϕ is affinely invariant and if x is ellipsoidally sym-
metric, then rerandomization is EPVR for x and any linear function of x.
Rerandomization methods that are not affinely invariant could increase
the variance of some linear combinations of covariates [Rubin (1976)].
Although affinely invariant methods have desirable properties in general,
they are not always preferred. For example, if covariates are known to vary
in importance, a rerandomization method that is not EPVR may be more
desirable, allowing greater percent reduction in variance for more important
covariates. Rerandomization criteria that take into account covariates of
varying importance are discussed in Lock [(2011), Chapter 4].
5. Discussion.
5.1. Alternatives for balancing covariates. Rerandomization is certainly
not the only way to balance covariates before the experiment.
With only a few categorical covariates, simple blocking can successfully
balance all covariates, and there is no need for rerandomization. With many
covariates each taking on many values, however, blocking on all covari-
ates can be impossible, and in this case we recommend blocking on the
most important covariates, and rerandomizing to balance the components of
the covariates orthogonal to the blocks. Blocking and rerandomization can,
and we feel should, be used together. Multivariate matching [Greevy et al.
(2004); Rubin (2006); Ho et al. (2007); Imai, King and Nall (2009); Xu and
Kalbfleisch (2010)] is a special case of blocking that can better handle many
covariates.
Restricted (or constrained) randomization [Yates (1948); Grundy and
Healy (1950); Youden (1972); Bailey (1983)] restricts the set of acceptable
randomizations in a way that preserves the validity of asymptotic-based
distributional methods of analysis. However, most work on restricted ran-
domization is specific to agricultural plots, and apparently has not been
extended to multiple covariates. Blocking, matching and restricted random-
ization can all also be implemented through rerandomization by specifying
the set of acceptable randomizations through ϕ.
The Finite Selection Model (FSM) [Morris (1979); Morris and Hill (2000)]
provides balance for multiple covariates, but provides a fixed amount of bal-
ance in a fixed amount of computational time. Rerandomization has the
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flexibility to choose the desired tradeoff between balance and computa-
tional time. More details comparing FSM with rerandomization are in [Lock
(2011), Section 5.5].
Covariate-adaptive randomization schemes [Efron (1971); White and Freed-
man (1978); Pocock and Simon (1975); Pocock (1979); Simon (1979); Birkett
(1985); Aickin (2001); Atkinson (2002); Scott et al. (2002); McEntegart (2003);
Rosenberger and Sverdlov (2008)] are designed for clinical trials with se-
quential treatment allocation over extended periods of time. Rerandomiza-
tion as proposed here is not applicable to sequential allocation, and instead
readers interested in such trials can refer to the above sources.
If covariates are not balanced before the experiment, post-hoc methods
such as regression adjustment are commonly used, which rely on assumptions
that often cannot be verified [Tukey (1993); Freedman (2008)]. Moreover,
unlike post-hoc methods, rerandomization is conducted entirely at the design
stage, and so cannot be influenced by outcome data. Tukey (1993) and Rubin
(2008b) give convincing reasons for why as much as possible should be done
in the design phase of an experiment, before outcome data are available,
rather than in the analysis stage when the researcher has the potential to
bias the results, consciously or unconsciously.
5.2. Extensions and additional considerations. For multiple treatment
groups, any of the test statistics commonly used in multivariate analysis
of variance (MANOVA) can be used to measure balance. The standard
statistics are all equivalent to Mahalanobis distance in the special case of
two groups. Extensions for multiple treatment groups are discussed in Lock
[(2011), Section 5.2].
For unbiased estimates using rerandomization with treatment groups of
unequal sizes, multiple treatment groups of equal size can be created, and
then merged as needed after the rerandomization procedure, but before the
physical experiment. If extra units are discarded to form equal sized treat-
ment groups and rerandomization is employed, precision can actually in-
crease if covariates are highly correlated with the outcome [Lock (2011),
Section 5.3].
In a Bayesian analysis, as long as all covariates relevant to ϕ(x,W) are
conditioned on, the design is ignorable [Rubin (1978)], and theoretically, the
analysis can proceed as usual.
6. Conclusion. Randomization balances covariates across treatment
groups, but only on average, and in any one experiment covariates may
be unbalanced. Rerandomization provides a simple and intuitive way to im-
prove covariate balance in randomized experiments.
To perform rerandomization, a criterion determining whether a random-
ization is acceptable needs to be specified. For unbiasedness, this rule needs
to be symmetric regarding the treatment groups. If the criterion is affinely
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invariant, then for ellipsoidally symmetric distributions, balance improve-
ment will be the same for all covariates (and all linear combinations of the
covariates), and correlations between covariate differences in means will be
maintained. One such criterion is to rerandomize whenever Mahalanobis
distance exceeds a certain threshold.
When the covariates are correlated with the outcome, rerandomization in-
creases precision. If the analysis reflects the rerandomization procedure, this
leads to more precise estimates, more powerful tests and narrower confidence
intervals.
APPENDIX
Proof of Theorem 3.1. Because M ∼ χ2k under pure randomization
when the covariate means are normally distributed, rerandomization affects
the mean of M as follows:
E(M | x,M ≤ a) =
(1/(Γ(k/2)2k/2))
∫ a
0 y
k/2e−y/2 dy
(1/(Γ(k/2)2k/2))
∫ a
0 y
k/2−1e−y/2 dy
=
∫ a
0 (y/2)
k/2e−y/2 dy
(1/2)
∫ a
0 (y/2)
k/2−1e−y/2 dy
(23)
= 2×
γ(k/2 + 1, a/2)
γ(k/2, a/2)
.
To prove (8), we convert the covariates to canonical form [Rubin and
Thomas (1992)]. Let Σ= cov(XT −XC | x), and define
Z≡Σ−1/2(XT −XC),(24)
where Σ−1/2 is the Cholesky square root of Σ−1, so Σ−1/2
′
Σ−1/2 =Σ−1. By
the assumption of normality,
Z | x∼Nk(0, I).
Due to normality, uncorrelated implies independent and thus the elements
of Z are independent and identically distributed (i.i.d.) standard normals.
Therefore, the elements of Z are exchangeable.
By (5), M = Z′Z=
∑k
j=1Z
2
j . Therefore for each j we have
var(Zj | x,M ≤ a) = E(Z
2
j | x,M ≤ a)
=
E(M | x,M ≤ a)
k
(25)
=
2
k
×
γ(k/2 + 1, a/2)
γ(k/2, a/2)
= va,(26)
where (25) follows from the exchangeability of the elements of Z.
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After enforcingM ≤ a, the elements of Z are no longer independent (they
will be negatively correlated in magnitude), but with signs they remain
uncorrelated due to symmetry:
cov(Zi,Zj | x,M ≤ a) = E(ZiZj | x,M ≤ a)
−E(Zi | x,M ≤ a)E(Zj | x,M ≤ a)
= E(E(ZiZj | Zj ,x,M ≤ a) | x,M ≤ a)− 0(27)
= E(ZjE(Zi | Zj ,x,M ≤ a) | x,M ≤ a)
= E(Zj × 0 | x,M ≤ a)(28)
= 0,(29)
where (27) follows from Corollary 2.2, and (28) follows because (Zi | Zj,M ≤
a)∼ (−Zi | Zj,M ≤ a), thus E(Zi | Zj,M ≤ a) = 0 for all i, j.
Thus after rerandomization the covariance matrix of Z is vaI, hence
cov(XT −XC | x,M ≤ a) = cov(Σ
1/2Z | x,M ≤ a)
=Σ1/2 cov(Z | x,M ≤ a)Σ1/2′
= vaΣ
= va cov(XT −XC | x). 
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